Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369989 · ClinicalTrials.gov registry record
Observational Study of COVID-19 Treatment Efficacy
A clinical trial, sponsored by OSF Healthcare System.
- Terminated
- Registry status
- 250
- Enrollment target
NCT04369989: Clinical Trial study, sponsored by OSF Healthcare System.
NCT04369989 is a clinical trial that was terminated before completion, run by OSF Healthcare System. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04369989 was terminated before completion, sponsored by OSF Healthcare System.
- TERMINATED
- Registry status
- 250 participants
- Enrollment target
Study Summary
To compare various treatments provided to positive COVID-19 patients at locations across the OSF Ministry. Provide the opportunity to compare the effectiveness of various treatments and treatment timelines provided to specific cohorts of patients that have the potential to impact future treatment plans for COVID-19 patients and/or future research hypotheses.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-04-14 |
| Est. Completion | 2021-04-14 |
Why NCT04369989 stopped before completion
NCT04369989 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04369989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04369989 about?
NCT04369989 is a clinical study titled "Observational Study of COVID-19 Treatment Efficacy". To compare various treatments provided to positive COVID-19 patients at locations across the OSF Ministry. Provide the opportunity to compare the effectiveness of various treatments and treatment timelines provided to specific cohorts of patients that have the potential to impact future treatment pl...
What is the current status of trial NCT04369989?
This trial is currently terminated. The enrollment target is 250 participants. The study started on 2020-04-14. Estimated completion is 2021-04-14.
What interventions are being tested in trial NCT04369989?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04369989?
This trial is sponsored by OSF Healthcare System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI